DEF — Defense
CDMRP's PRCRP
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
4e9e2df2-7eb9-4c6a-8bc8-e5d18be60940Q1 — 1st Quarter - ReportINTERNATIONAL MYELOMA FOUNDATION
patient advocacy organization
INTERNATIONAL MYELOMA FOUNDATION
DEF — DefenseCDMRP's PRCRP
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
BUD — Budget/AppropriationsH.R. 9747, (P.L. 118-83) the FY2025 Continuing Appropriations and Extensions Act: Cancer Research, Appropriations: Cancer Research, NIH, CDC, NCI, DoD, ARPA-H,
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
HCR — Health IssuesAccess Issues, Cancer Drug Parity Act, Safe Step Act, Seniors Timely Access to Care Act
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.